Could a Lookalike Drug in a Nanocarrier Evade Lung Cancer's Defenses?
Researchers have made a groundbreaking discovery in the fight against lung cancer—a nanocarrier that can camouflage as a common drug to evade the body’s defense mechanisms. This could potentially revolutionize the way we deliver cancer treatments and improve patient outcomes. How does this nanocarrier work, and what are the implications for the future of cancer treatment? These are questions that researchers are racing to answer as they continue to explore the potential of this innovative approach.
source: Phys.org